DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

CREDITACCESS GRAMEEN LIMITED — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·24 Jul 2026, 2:32 pm

Creditaccess Grameen

CreditAccess Grameen has announced the schedule for its upcoming analyst and institutional investor conference call. This meeting is a standard corporate practice where the company management outlines its business performance and future outlook to the financial community.

For investors, this update is significant as it provides an opportunity to hear directly from the company's leadership. The discussion is expected to cover recent financial results, strategic initiatives, and guidance for the future, which can help clarify the company's trajectory and market position.

Investors should watch for key takeaways regarding the company's asset quality, loan growth, and capital adequacy. Any comments on the microfinance sector's regulatory environment or operational efficiency will also be important factors to consider when evaluating the stock.